Rainer Kaiser/LInkedIn
Jul 12, 2026, 20:21
Rainer Kaiser: How T Cells Boost Myeloid Effector Functions in Endocarditis
Rainer Kaiser, Internal Medicine and Cardiology Specialist at LMU Klinikum München, shared a post on LinkedIn:
“For an exciting update on our most recent take on translational immunothrombosis research, come and join us for the session ‘Bacterial impact on immunothrombosis’ to learn how T cells boost myeloid effector functions in endocarditis.
- Monday, July 13th
- 10:15 am (session starts at 09:30 am)
- Room W05-06
See you in Paris!”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring
-
Aug 11, 2026, 14:30Bharat Moyal: The New KDIGO 2026 Approach to Anemia in CKD